PERRICONE, ROBERTO
 Distribuzione geografica
Continente #
NA - Nord America 58.125
AS - Asia 6.457
EU - Europa 5.747
SA - Sud America 849
AF - Africa 132
OC - Oceania 97
Continente sconosciuto - Info sul continente non disponibili 10
Totale 71.417
Nazione #
US - Stati Uniti d'America 57.933
SG - Singapore 3.087
CN - Cina 1.427
DE - Germania 832
RU - Federazione Russa 819
BR - Brasile 722
UA - Ucraina 700
IT - Italia 686
FR - Francia 599
IE - Irlanda 590
HK - Hong Kong 584
FI - Finlandia 511
VN - Vietnam 478
GB - Regno Unito 344
SE - Svezia 254
JP - Giappone 173
KR - Corea 169
IN - India 108
CA - Canada 103
PL - Polonia 76
NL - Olanda 72
BE - Belgio 66
MX - Messico 61
AU - Australia 53
BD - Bangladesh 53
ID - Indonesia 46
NZ - Nuova Zelanda 43
ES - Italia 42
TW - Taiwan 42
ZA - Sudafrica 42
AR - Argentina 41
DK - Danimarca 36
IQ - Iraq 36
UZ - Uzbekistan 35
IR - Iran 30
TR - Turchia 30
PK - Pakistan 27
EC - Ecuador 23
SA - Arabia Saudita 23
AT - Austria 20
MA - Marocco 20
EG - Egitto 19
PH - Filippine 18
MY - Malesia 17
LT - Lituania 16
AE - Emirati Arabi Uniti 15
CO - Colombia 15
CL - Cile 13
RO - Romania 13
LV - Lettonia 11
CZ - Repubblica Ceca 10
KE - Kenya 10
TN - Tunisia 10
VE - Venezuela 10
ET - Etiopia 8
GR - Grecia 8
IL - Israele 8
PE - Perù 8
KG - Kirghizistan 7
UY - Uruguay 7
DZ - Algeria 6
HU - Ungheria 6
JO - Giordania 6
PY - Paraguay 6
BG - Bulgaria 5
DO - Repubblica Dominicana 5
LB - Libano 5
NP - Nepal 5
PA - Panama 5
SI - Slovenia 5
TH - Thailandia 5
A2 - ???statistics.table.value.countryCode.A2??? 4
AL - Albania 4
CH - Svizzera 4
EU - Europa 4
GH - Ghana 4
HN - Honduras 4
OM - Oman 4
BH - Bahrain 3
BO - Bolivia 3
GE - Georgia 3
JM - Giamaica 3
NO - Norvegia 3
PT - Portogallo 3
SN - Senegal 3
YE - Yemen 3
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CI - Costa d'Avorio 2
CR - Costa Rica 2
GA - Gabon 2
HR - Croazia 2
KZ - Kazakistan 2
LK - Sri Lanka 2
MD - Moldavia 2
NG - Nigeria 2
NI - Nicaragua 2
PS - Palestinian Territory 2
RS - Serbia 2
Totale 71.398
Città #
Woodbridge 15.549
Wilmington 15.051
Houston 13.914
Singapore 1.642
Fairfield 1.633
Ann Arbor 1.432
Chandler 1.084
Ashburn 1.056
Seattle 648
San Jose 610
Jacksonville 594
Hong Kong 575
Cambridge 538
Dublin 514
Beijing 472
Medford 421
Helsinki 368
New York 356
Dallas 308
The Dalles 302
Santa Clara 240
Los Angeles 232
Lawrence 196
Dearborn 192
Rome 186
Council Bluffs 151
Lauterbourg 148
Ho Chi Minh City 136
Moscow 136
Zhengzhou 124
Hanoi 117
Tokyo 107
Buffalo 86
São Paulo 84
Chicago 79
Menlo Park 79
San Diego 75
Boardman 74
Mülheim 71
Redwood City 70
London 61
Milan 57
Munich 54
Brussels 53
Nanjing 53
Shanghai 46
Tauranga 42
Falls Church 41
Norwalk 40
Toronto 40
Palo Alto 39
Seoul 39
Kraków 36
Nuremberg 36
Orem 36
Redondo Beach 35
Copenhagen 34
Amsterdam 33
Stockholm 32
Phoenix 31
Warsaw 31
Johannesburg 30
Mountain View 30
Hefei 29
Frankfurt am Main 28
Shenzhen 28
Columbus 27
Denver 27
Guangzhou 27
Kunming 27
Chengdu 26
San Mateo 26
Verona 26
Jakarta 25
Melbourne 25
Suzhou 24
University Park 24
Brooklyn 23
Haiphong 22
Montreal 22
Taipei 22
Atlanta 21
Chennai 21
Chongqing 20
North Bergen 20
Boston 19
Rio de Janeiro 19
San Francisco 19
Baghdad 17
Dong Ket 16
Augusta 15
Da Nang 15
Belo Horizonte 14
Curitiba 14
Jeddah 14
Porto Alegre 14
Brasília 13
Jinan 13
Paris 13
Poplar 13
Totale 61.347
Nome #
Challenges in the treatment of Rheumatoid Arthritis 834
Itch gene polymorphisms in healthy population and in patients affected by rheumatoid arthritis and atopic dermatitis 560
Serum thymosin α 1 levels in patients with chronic inflammatory autoimmune diseases 539
Gonadal mosaicism in hereditary angioedema 528
Complement and autoimmunity 526
Complement, infection, and autoimmunity 521
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 511
Peripheral blood natural killer cells and mild thyroid abnormalities in women with reproductive failure 509
NK cells in autoimmunity: A two-edg'd weapon of the immune system 504
Synovial fluid from patients with rheumatoid arthritis modulates monocyte cell-surface phenotype 504
A nationwide survey of hereditary angioedema due to C1 inhibitor deficiency in Italy 500
Autoantibodies in inflammatory arthritis 500
Serum thymosin alpha 1 levels in normal and pathological conditions 495
C3 come indicatore di efficacia terapeutica in pazienti con artrite reumatoide in terapia con inibitori del TNFα 492
Glutathione: A key player in autoimmunity 491
Vasculitides and the Complement System: a Comprehensive Review 489
Stem cells in autoimmune diseases: Implications for pathogenesis and future trends in therapy 487
High levels of peripheral blood NK cells in women suffering from recurrent spontaneous abortion are reverted from high-dose intravenous immunoglobulins 484
Denaturing HPLC in laboratory diagnosis of hereditary angioedema 483
Anti-TNFα discontinuation in rheumatoid and psoriatic arthritis: Is it possible after disease remission? 483
Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion 482
Differential expression of stromal cell-derived factor 1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implications 481
Normal fetal growth in women with antiphospholipid syndrome treated with high-dose intravenous immunoglobulin (IVIG) 480
Efficacy and Safety of Subcutaneous Anti-Tumor Necrosis Factor-Alpha Agents, Etanercept and Adalimumab, in Elderly Patients Affected by Psoriasis and Psoriatic Arthritis: An Observational Long-Term Study 479
Anti-thyroid antibodies and antiphospholipid syndrome: Evidence of reduced fecundity and of poor pregnancy outcome in recurrent spontaneous aborters 477
Apremilast for the treatment of psoriasis. 474
Evidence of impaired sense of smell in hereditary angioedema 472
An impaired endothelial dependent and independent vasodilation characterizes the myo-endothelial dysfunction in ssc patients 472
Expression of immunoglobulin-like transcript 4 as an inhibitory receptor in patients with psoriatic arthritis 470
Prolactin and natural killer cells: Evaluating the neuroendocrine-immune axis in women with primary infertility and recurrent spontaneous abortion 467
Serological markers associated with disease activity in patients with rheumatoid arthritis treated with rituximab 466
Remission and low disease activity in a cohort of real-life patients with rheumatoid arthritis treated with first-line antitumour necrosis factor 463
Long-term treatment with adalimumab in psoriatic arthritis: serum adalimumab concentration, immunogenicity and the link with clinical response 463
Role of the complement system in rheumatoid arthritis and psoriatic arthritis: Relationship with anti-TNF inhibitors 456
High-dose intravenous immunoglobulin treatment activates complement in vivo 455
Hereditary and acquired angioedema: Problems and progress: Proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 455
Adalimumab corrects long-term endothelial dysfunction in rheumatoid arthritis 454
Emergence of antinuclear antibodies in psoriatic patients treated with infliximab: personal experience and literature review 454
Golimumab in Patients Affected by Moderate to Severe Psoriatic Arthritis: An Open-Label Study in Thirty-Two Patients Previously Treated with Other Biologics 453
Self-reported adherence to a home-based exercise program among patients affected by psoriatic arthritis with minimal disease activity 453
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 453
Adalimumab and polymyalgia rheumatica. clinical remission but persisting high levels of esr: a controversy 451
Complement activation and sensitizing antibodies in lyme borreliosis - a microbial adherence immobilization assay for borrelia-burgdorferi (maia-bb) 451
Profile of certolizumab and its potential in the treatment of psoriatic arthritis 451
Recurrent Angioedema: Occurrence, Features, and Concomitant Diseases in an Italian Single-Center Study 451
Complement system in psoriatic arthritis: a useful marker in response prediction and monitoring of anti-TNF treatment. 450
Use of anti-tumor necrosis factor alpha therapy in patients with concurrent rheumatoid arthritis and hepatitis B or hepatitis C: a retrospective analysis of 32 patients 450
Anti-Saccharomyces cerevisiae Autoantibodies in Autoimmune Diseases: from Bread Baking to Autoimmunity 449
The type I IFN system in rheumatoid arthritis 444
Complement system in rheumatoid arthritis: evidence of correlation with disease activity but not with anti-citrullinated protein antibodies 444
Sistema complementare e artrite reumatoide: Correlazioni con autoanticorpi, caratteristiche cliniche e di laboratorio e farmaci anti-TNF α 444
Retinal functional changes measured by frequency-doubling technology in patients treated with hydroxychloroquine. 442
Polymorphisms in STAT4, PTPN2, PSORS1C1 and TRAF3IP2 genes are associated with the response to TNF inhibitors in patients with rheumatoid arthritis 442
Scleroderma heart involvement: non-invasive assessment of pathophysiological mechanism and its effect on prognosis 441
Occurrence of localized scleroderma morphea in a patient with rheumatoid arthritis treated with etanercept 437
Association of psoriasis and/or psoriatic arthritis with autoimmune diseases: The experience of two Italian integrated Dermatology/Rheumatology outpatient clinics 436
The new era for the treatment of psoriasis and psoriatic arthritis: perspectives and validated strategies 436
Antimyocardial Autoantibodies (AMCA) 436
The European register of hereditary angioedema: Experience and preliminary results 435
Evaluation of clinical and ultrasonographic parameters in psoriatic arthritis patients treated with adalimumab: a retrospective study 435
GM-CSF and pregnancy: Evidence of significantly reduced blood concentrations in unexplained recurrent abortion efficiently reverted by intravenous immunoglobulin treatment 433
HELLP syndrome: A complication or a new autoimmune syndrome? 433
Evidence-based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: Consensus report of an International Working Group 433
Prediction of early pregnancy maternal thyroid impairment in women affected with unexplained recurrent miscarriage. 431
Auto-reactions, autoimmunity and psoriatic arthritis 429
European consensus for gynecologycal and obstetric management of women with hereditary angioedema due to C1-inhibitor deficiency (HAE): PREHAEAT 428
The autoimmune side of hereditary angioedema: Insights on the pathogenesis 427
ADA genetic polymorphism and total plasma IgE level in healthy adults 426
Cytokine production by human fetal membranes and uterine decidua at term gestation in relation to labor 425
Metabolic profiling of human CD4+ cells following treatment with methotrexate and anti-TNF-α infliximab 425
Functionally active complement is present in human ovarian follicular fluid and can be activated by seminal plasma. 424
Complement system and rheumatoid arthritis: relationships with autoantibodies, serological, clinical features, and anti-TNF treatment 424
Behcet's disease and etanercept: eighty weeks of experience 424
A 2-year observational study on treatment targets in psoriatic arthritis patients treated with TNF inhibitors 423
TREATMENT OF RECURRENT SPONTANEOUS ABORTION WITH HIGH-DOSE INTRAVENOUS IMMUNOGLOBULIN 420
Cystic ovaries in women affected with hereditary angioedema. 419
Small-medium vessel vasculitides: Is the complement system a potential forgotten target? 419
Resolution with rituximab of localized scleroderma occurring during etanercept treatment in a patient with rheumatoid arthritis 419
Complement system in psoriatic arthritis: a useful marker and a potential therapeutic target of anti-tnf-alpha treatment 418
Inhibition of the complement system by glutathione: molecular mechanisms and potential therapeutic implications 417
'Autoimmunity cutting edge at the 21st century. Representation of the 9th international congress of autoimmunity, nice, France 2014' 416
BETA ENDORPHIN INTERACTION WITH LFA 1 (CD11A/CD18) ON HUMAN PERIPHERAL BLOOD LYMPHOCYTES 415
Differential expression of SDF-1 and its receptor CXCR4 in the skin and endothelial cells of systemic sclerosis patients: Pathogenetic implication 414
Successful high dose intravenous immunoglobulin treatment of a pregnant patient affected with hypereosinophilia syndrome and antiphospholipid syndrome (aPL plus recurrent spontaneous abortion) 413
Resistance to apoptosis in circulating alpha/beta and gamma/delta T lymphocytes from patients with systemic sclerosis 411
Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond 411
Downregulation of immunoglobulin-like transcript-4 (ILT4) in patients with psoriatic arthritis 410
Immunomodulation in psoriatic arthritis: focus on cellular and molecular pathways 409
Comment on: Intravenous immunoglobulin therapy in pregnant patients affected with systemic lupus erythematosus and recurrent spontaneous abortion: reply 408
Insights on the role of physical activity in patients with rheumatoid arthritis 408
S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis 408
Discontinuation of anti-TNFα therapy due to remission in rheumatoid arthritis: A retrospective study 408
Remission of psoriatic arthritis after etanercept discontinuation: analysis of patients' clinical characteristics leading to disease relapse 406
Restoration of peripheral blood natural killer and B cell levels in patients affected by rheumatoid and psoriatic arthritis during etanercept treatment 405
The interplay between inflammation and metabolism in rheumatoid arthritis 405
NK cells, autoantibodies, and immunologic infertility: a complex interplay 404
The autoreactivity of B cells in hereditary angioedema due to C1 inhibitor deficiency 403
Complement deficiency and antibody profile in survivors of meningococcal meningitis due to common serogroups in Italy 402
Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts 402
Hereditary angioneurotic edema: clinical and laboratory findings in 58 subjects 401
Totale 45.300
Categoria #
all - tutte 157.901
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 157.901


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021719 0 0 0 0 0 0 0 0 0 240 382 97
2021/20222.080 108 221 157 118 84 128 101 99 101 198 180 585
2022/20232.657 241 230 97 369 252 582 205 162 264 39 154 62
2023/20241.028 132 41 48 35 85 317 29 106 19 26 16 174
2024/20254.624 181 984 494 275 105 308 215 185 436 417 585 439
2025/20267.710 596 338 1.094 833 820 385 1.212 941 873 618 0 0
Totale 72.153